{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:53:16Z","timestamp":1791035596200,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.prp.2026.156702","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:24:42Z","timestamp":1790954682000},"page":"156702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["FOXM1-mediated transcriptional activation of CILP2 promotes malignant phenotypes and EMT-associated remodeling in clear cell renal cell carcinoma"],"prefix":"10.1016","volume":"288","author":[{"given":"Jiajia","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongzhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jikai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.prp.2026.156702_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41419-023-06090-7","article-title":"The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling","volume":"14","author":"Shi","year":"2023","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.prp.2026.156702_bib2","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"12","key":"10.1016\/j.prp.2026.156702_bib3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal Cell Carcinoma: A Review","volume":"332","author":"Rose","year":"2024","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.prp.2026.156702_bib4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41419-024-07136-0","article-title":"USP7 depletion potentiates HIF2\u03b1 degradation and inhibits clear cell renal cell carcinoma progression","volume":"15","author":"Tu","year":"2024","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.prp.2026.156702_bib5","doi-asserted-by":"crossref","first-page":"g4797","DOI":"10.1136\/bmj.g4797","article-title":"Renal cell carcinoma","volume":"349","author":"Jonasch","year":"2014","journal-title":"Bmj"},{"issue":"6","key":"10.1016\/j.prp.2026.156702_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","article-title":"European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update","volume":"87","author":"Bex","year":"2025","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.prp.2026.156702_bib7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ccell.2021.03.007","article-title":"Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy","volume":"39","author":"Krishna","year":"2021","journal-title":"Cancer Cell."},{"issue":"3","key":"10.1016\/j.prp.2026.156702_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"Havel","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2026.156702_bib9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"issue":"7528","key":"10.1016\/j.prp.2026.156702_bib10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.prp.2026.156702_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167202","article-title":"CILP2 promotes hypertrophic scar through Snail acetylation by interaction with ACLY","volume":"1870","author":"Wang","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"43","key":"10.1016\/j.prp.2026.156702_bib12","doi-asserted-by":"crossref","first-page":"37758","DOI":"10.1074\/jbc.M111.248039","article-title":"Cartilage intermediate layer protein 2 (CILP-2) is expressed in articular and meniscal cartilage and down-regulated in experimental osteoarthritis","volume":"286","author":"Bernardo","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.prp.2026.156702_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.joca.2015.09.020","article-title":"Fibrotic-like changes in degenerate human intervertebral discs revealed by quantitative proteomic analysis","volume":"24","author":"Yee","year":"2016","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.prp.2026.156702_bib14","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.014159","article-title":"Changes in the chondrocyte and extracellular matrix proteome during post-natal mouse cartilage development","volume":"11","author":"Wilson","year":"2012","journal-title":"Mol. Cell. Proteom."},{"issue":"8","key":"10.1016\/j.prp.2026.156702_bib15","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","article-title":"The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics","volume":"14","author":"Prakash","year":"2024","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.prp.2026.156702_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.tcb.2022.02.008","article-title":"Extracellular matrix remodeling facilitates obesity-associated cancer progression","volume":"32","author":"Kim","year":"2022","journal-title":"Trends Cell. Biol."},{"issue":"5","key":"10.1016\/j.prp.2026.156702_bib17","article-title":"CILP2: A prognostic biomarker associated with immune infiltration in colorectal cancer","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.prp.2026.156702_bib18","article-title":"CILP, a Putative Gene Associated With Immune Infiltration in Breast Cancer Brain Metastases","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.prp.2026.156702_bib19","doi-asserted-by":"crossref","first-page":"12487","DOI":"10.1038\/s41598-024-63366-4","article-title":"CILP2 is a potential biomarker for the prediction and therapeutic target of peritoneal metastases in colorectal cancer","volume":"14","author":"Ha","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2026.156702_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.03.007","article-title":"FOXM1: A small fox that makes more tracks for cancer progression and metastasis","volume":"92","author":"Khan","year":"2023","journal-title":"Semin. Cancer Biol."},{"issue":"Pt 3","key":"10.1016\/j.prp.2026.156702_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcancer.2022.07.009","article-title":"Dysregulated FOXM1 signaling in the regulation of cancer stem cells","volume":"86","author":"Sher","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.prp.2026.156702_bib22","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1080\/15548627.2023.2284523","article-title":"Transcription factor FOXM1 specifies chromatin DNA to extracellular vesicles","volume":"20","author":"Zhang","year":"2024","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.prp.2026.156702_bib23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bcp.2012.10.013","article-title":"Targeting FOXM1 in cancer","volume":"85","author":"Halasi","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.prp.2026.156702_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semcancer.2014.07.008","article-title":"FOXM1: A key oncofoetal transcription factor in health and disease","volume":"29","author":"Bella","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.prp.2026.156702_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108349","article-title":"FOXM1 facilitates breast cancer cell stemness and migration in YAP1-dependent manner","volume":"685","author":"Sun","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.prp.2026.156702_bib26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.prp.2026.156702_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12935-024-03502-2","article-title":"CTCF-activated FUCA1 functions as a tumor suppressor by promoting autophagy flux and serum \u03b1-L-fucosidase serves as a potential biomarker for prognosis in ccRCC","volume":"24","author":"Zhao","year":"2024","journal-title":"Cancer Cell. Int."},{"issue":"8","key":"10.1016\/j.prp.2026.156702_bib28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"45","author":"Sato","year":"2013","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.prp.2026.156702_bib29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.prp.2026.156702_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12967-024-05186-8","article-title":"Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model","volume":"22","author":"Zheng","year":"2024","journal-title":"J. Transl. Med."},{"issue":"24","key":"10.1016\/j.prp.2026.156702_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15245842","article-title":"The Prognostic and Immune Significance of CILP2 in Pan-Cancer and Its Relationship with the Progression of Pancreatic Cancer","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2026.156702_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2024.04.001","article-title":"Alternative splicing in EMT and TGF-\u03b2 signaling during cancer progression","volume":"101","author":"Zhang","year":"2024","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156702_bib33","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41392-022-01132-6","article-title":"Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis","volume":"7","author":"Jinesh","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2026.156702_bib34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2020.05.012","article-title":"Hypoxia-induced epithelial to mesenchymal transition in cancer","volume":"487","author":"Hapke","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2026.156702_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153437","article-title":"Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT\/mTOR signaling pathway","volume":"81","author":"Wu","year":"2021","journal-title":"Phytomedicine"},{"issue":"19","key":"10.1016\/j.prp.2026.156702_bib36","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1158\/0008-5472.CAN-15-3419","article-title":"Visualizing Epithelial-Mesenchymal Transition Using the Chromobody Technology","volume":"76","author":"Maier","year":"2016","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2026.156702_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189015","article-title":"Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments","volume":"1878","author":"Raghuwanshi","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"8","key":"10.1016\/j.prp.2026.156702_bib38","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ccell.2025.05.017","article-title":"Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma","volume":"43","author":"Huang","year":"2025","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.prp.2026.156702_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-019-1019-x","article-title":"CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer","volume":"18","author":"Hu","year":"2019","journal-title":"Mol. Cancer"},{"issue":"Pt 2","key":"10.1016\/j.prp.2026.156702_bib40","first-page":"136","article-title":"TGF-\u03b2 in developmental and fibrogenic EMTs","volume":"86","author":"Lee","year":"2022","journal-title":"Semin. Cancer Biol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:59:33Z","timestamp":1791032373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826003559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"alternative-id":["S0344033826003559"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156702","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOXM1-mediated transcriptional activation of CILP2 promotes malignant phenotypes and EMT-associated remodeling in clear cell renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156702"}}